Sentence: Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma .
Drug combination annotation:
[{'class': 'NEG', 'spans': ['temsirolimus', 'sunitinib'], 'is_context_needed': True}]